Abstract
Gabapentin is an anti-epileptic agent but now it is also recommended as first line agent in neuropathic pain, particularly in diabetic neuropathy and post herpetic neuralgia. α2δ-1, an auxillary subunit of voltage gated calcium channels, has been documented as its main target and its specific binding to this subunit is described to produce different actions responsible for pain attenuation. The binding to α2δ-1 subunits inhibits nerve injury-induced trafficking of α1 pore forming units of calcium channels (particularly N-type) from cytoplasm to plasma membrane (membrane trafficking) of pre-synaptic terminals of dorsal root ganglion (DRG) neurons and dorsal horn neurons. Furthermore, the axoplasmic transport of α2δ-1 subunits from DRG to dorsal horns neurons in the form of anterograde trafficking is also inhibited in response to gabapentin administration. Gabapentin has also been shown to induce modulate other targets including transient receptor potential channels, NMDA receptors, protein kinase C and inflammatory cytokines. It may also act on supra-spinal region to stimulate noradrenaline mediated descending inhibition, which contributes to its anti-hypersensitivity action in neuropathic pain.
Similar content being viewed by others
References
Alden, K.J., and J. Garcia. 2001. Differential effect of gabapentin on neuronal and muscle calcium currents. Journal of Pharmacology and Experimental Therapeutics 297: 727–735.
Amr, Y.M. 2010. Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: A prospective, randomized, double blind trial. Pain Physician 13: 245–249.
Arai, Y.C., T. Matsubara, K. Shimo, K. Suetomi, M. Nishihara, T. Ushida, K. Kobayashi, C. Suzuki, A. Kinoshita, M. Kondo, S. Matsubara, R. Hayashi, Y. Tohyama, K. Nishida, and M. Arakawa. 2010. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. Journal of Anesthesia 24: 407–410.
Argoff, C.E. 2011. Review of current guidelines on the care of post herpetic neuralgia. Postgraduate Medicine 123: 134–142.
Attal, N., G. Mazaltarine, B. Perrouin-Verbe, T. Albert, and SOFMER French Society for Physical Medicine and Rehabilitation. 2009. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous). Annals of Physical and Rehabilitation Medicine 52: 124–141.
Baba, H., K. Shimoji, and M. Yoshimura. 2000. Norepinephrine facilitates inhibitory transmission in substantia gelatinosa of adult rat spinal cord (part 1): Effects on axon terminals of GABAergic and glycinergic neurons. Anesthesiology 92: 473–484.
Back, S.K., S.Y. Won, S.K. Hong, and H.S. Na. 2004. Gabapentin relieves mechanical, warm and cold allodynia in a rat model of peripheral neuropathy. Neuroscience Letters 368: 341–344.
Backonja, M., A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. LaMoreaux, and E. Garofalo. 1998. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 280: 1831–1836.
Backonja, M.M., D.M. Canafax, and K.C. Cundy. 2011. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Pain Medicine 12: 1098–1108.
Backonja, M., and R.L. Glanzman. 2003. Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials. Clinical Therapeutics 25: 81–104.
Bang, S., S. Yoo, and S.W. Hwang. 2009. Gabapentin attenuates the activation of transient receptor potential A1 by cinnamaldehyde. Experimental Neurobiology 18: 1–7.
Bauer, C.S., M. Nieto-Rostro, W. Rahman, A. Tran-Van-Minh, L. Ferron, L. Douglas, I. Kadurin, Y. Sri Ranjan, L. Fernandez-Alacid, N.S. Millar, A.H. Dickenson, R. Lujan, and A.C. Dolphin. 2009. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. Journal of Neuroscience 29: 4076–4088.
Bautista, D.M., S.E. Jordt, T. Nikai, P.R. Tsuruda, A.J. Read, J. Poblete, E.N. Yamoah, A.I. Basbaum, and D. Julius. 2006. TRPA1 mediates the inflammatory actions of environment tal irritants and proalgesic agents. Cell 124: 1269–1282.
Berger, A., E. Dukes, B. McCarberg, M. Liss, and G. Oster. 2003. Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia. Clinical Therapeutics 25: 2809–2821.
Beydoun, A. 1999. Postherpetic neuralgia: Role of gabapentin and other treatment modalities. Epilepsia 40(Suppl 6): S51–S56.
Bilgir, O., M. Calan, F. Bilgir, L. Kebapçilar, A. Yüksel, Y. Yildiz, and I. Sari. 2009. Gabapentin-induced rhabdomyolysis in a patient with diabetic neuropathy. Internal Medicine 48: 1085–1087.
Biyik, Z., Y. Solak, H. Atalay, A. Gaipov, F. Guney, and S. Turk. 2012. Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: A randomized prospective crossover trial. International Urology and Nephrology, May 29. [Epub ahead of print].
Bodensteiner, J.B., H.H. Morris, and G.S. Golden. 1981. Asterixis associated with sodium valproate. Neurology 31: 195–196.
Bookwalter, T., and M. Gitlin. 2005. Gabapentin-induced neurologic toxicities. Pharmacotherapy 25: 1817–1819.
Boroujerdi, A., J. Zeng, K. Sharp, D. Kim, O. Steward, and Z.D. Luo. 2011. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain 152: 649–655.
Boulton, A.J. 2003. Treatment of symptomatic diabetic neuropathy. Diabetes/Metabolism Research and Reviews 19(Suppl 1): S16–S21.
Butterworth, R.F. 1996. Neuroactive aminoacids in hepatic encephalopathy. Metabolic Brain Disease 11: 165–173.
Cahill, C.M., and T.J. Coderre. 2002. Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain 95: 277–285.
Calabrò, R.S. 2011. Gabapentin and sexual dysfunction: An overlooked and underreported problem? Epilepsy & Behavior 22: 818.
Cantí, C., M. Nieto-Rostro, I. Foucault, F. Heblich, J. Wratten, M.W. Richards, J. Hendrich, L. Douglas, K.M. Page, A. Davies, and A.C. Dolphin. 2005. The metal-ion-dependent adhesion site in the Von Willebrand factor—A domain of alpha2delta subunits is key to trafficking voltage-gated Ca2+ channels. Proceedings of the National Academy of Sciences of the United States of America 102: 11230–11235.
Chandra, K., N. Shafiq, P. Pandhi, S. Gupta, and S. Malhotra. 2006. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: A randomized, double-blind clinical trial—the GONIP Trial. International Journal of Clinical Pharmacology and Therapeutics 44: 358–363.
Chen, S.R., and H.L. Pan. 2005. Effect of systemic and intrathecal gabapentin on allodynia in a new rat model of postherpetic neuralgia. Brain Research 1042: 108–113.
Cheshire, W.P. 2007. Trigeminal neuralgia: For one nerve a multitude of treatments. Expert Review of Neurotherapeutics 7: 1565–1579.
Chong, M.S., and J. Hester. 2007. Diabetic painful neuropathy: Current and future treatment options. Drugs 67: 569–585.
Chou, R., S. Carson, and B.K. Chan. 2009. Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: Discrepancies between direct and indirect meta-analyses of randomized controlled trials. Journal of General Internal Medicine 24: 178–188.
Chu, L.C., M.L. Tsaur, C.S. Lin, Y.C. Hung, T.Y. Wang, C.C. Chen, and J.K. Cheng. 2011. Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats. British Journal of Anaesthesia 106: 699–705.
Coderre, T.J., N. Kumar, C.D. Lefebvre, and J.S. Yu. 2007. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. Journal of Neurochemistry 100: 1289–1299.
Dallocchio, C., C. Buffa, P. Mazzarello, and S. Chiroli. 2000. Gabapentin vs. amitriptyline in painful diabetic neuropathy: An open-label pilot study. Journal of Pain and Symptom Management 20: 280–285.
Davies, A., J. Hendrich, A.T. Van Minh, J. Wratten, L. Douglas, and A.C. Dolphin. 2007. Functional biology of the alpha (2) delta subunits of voltage gated calcium channels. Trends in Pharmacological Sciences 28: 220–228.
Dworkin, R.H., A.B. O’Connor, M. Backonja, J.T. Farrar, N.B. Finnerup, T.S. Jensen, E.A. Kalso, J.D. Loeser, C. Miaskowski, T.J. Nurmikko, R.K. Portenoy, A.S. Rice, B.R. Stacey, R.D. Treede, D.C. Turk, and M.S. Wallace. 2007. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 132: 237–251.
Erdoğan, G., D. Ceyhan, and S. Güleç. 2011. Possible heart failure associated with pregabalin use: Case report. Agri 23: 80–83.
Ermis, N., H. Gullu, M. Caliskan, A. Unsal, M. Kulaksizoglu, and H. Muderrisoglu. 2010. Gabapentin therapy improves heart rate variability in diabetic patients with peripheral neuropathy. Journal of Diabetes and Its Complications 24: 229–233.
Field, M.J., P.J. Cox, E. Stott, H. Melrose, J. Offord, T.Z. Su, S. Bramwell, L. Corradini, S. England, J. Winks, R.A. Kinloch, J. Hendrich, A.C. Dolphin, T. Webb, and D. Williams. 2006. Identification of the α2-δ-1 subunit of voltage dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proceedings of the National Academy of Sciences of the United States of America 103: 17537–17542.
Folkesson, A., P.H. Honoré, L.M. Andersen, P. Kristensen, and O.J. Bjerrum. 2010. Low dose of donepezil improves gabapentin analgesia in the rat spared nerve injury model of neuropathic pain: Single and multiple dosing studies. Journal of Neural Transmission 117: 1377–1385.
Furuta, S., T. Shimizu, M. Narita, K. Matsumoto, N. Kuzumaki, S. Horie, T. Suzuki, and M. Narita. 2009. Subdiaphragmatic vagotomy promotes nociceptive sensitivity of deep tissue in rats. Neuroscience 164: 1252–1262.
Garry, E.M., A. Delaney, H.A. Anderson, E.C. Sirinathsinghji, R.H. Clapp, W.J. Martin, P.R. Kinchington, D.L. Krah, C. Abbadie, and S.M. Fleetwood-Walker. 2005. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118: 97–111.
Gassner, M., R. Ruscheweyh, and J. Sandkühler. 2009. Direct excitation of spinal GABAergic interneurons by noradrenaline. Pain 145: 204–210.
Geber, C., U. Baumgärtner, R. Schwab, H. Müller, P. Stoeter, M. Dieterich, C. Sommer, F. Birklein, and R.D. Treede. 2009. Revised definition of neuropathic pain and its grading system: An open case series illustrating its use in clinical practice. American Journal of Medicine 122(10 Suppl): S3–S12.
Gilron, I., J.M. Bailey, D. Tu, R.R. Holden, A.C. Jackson, and R.L. Houlden. 2009. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial. Lancet 374: 1252–1261.
Gilron, I., J.M. Bailey, D. Tu, R.R. Holden, D.F. Weaver, and R.L. Houlden. 2005. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine 352: 1324–1334.
Gurnett, C.A., M. De Waard, and K.P. Campbell. 1996. Dual function of the voltage dependent Ca2+ channel α2-δ subunit in current stimulation and subunit interaction. Neuron 16: 431–440.
Hanna, M., C. O’Brien, and M.C. Wilson. 2008. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. European Journal of Pain 12: 804–813.
Hansson, E., H. Muyderman, J. Leonova, L. Allansson, J. Sinclair, F. Blomstrand, T. Thorlin, M. Nilsson, and L. Rönnbäck. 2000. Astroglia and glutamate in physiology and pathology: Aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochemistry International 37: 317–329.
Hara, K., and T. Sata. 2007. Inhibitory effect of gabapentin on N-methyl-d-aspartate receptors expressed in Xenopus oocytes. Acta Anaesthesiologica Scandinavica 51: 122–128.
Haslam, C., and T. Nurmikko. 2008. Pharmacological treatment of neuropathic pain in older persons. Clinical Interventions in Aging 3: 111–120.
Hasnie, F.S., J. Breuer, S. Parker, V. Wallace, J. Blackbeard, I. Lever, P.R. Kinchington, A.H. Dickenson, T. Pheby, and A.S. Rice. 2007. Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behaviour, and the influence of analgesic drugs. Neuroscience 144: 1495–1508.
Hayashida, K., and J.C. Eisenach. 2008. Multiplicative interactions to enhance gabapentin to treat neuropathic pain. European Journal of Pharmacology 598: 21–26.
Hayashida, K., and J.C. Eisenach. 2011. A tropomyosine receptor kinase inhibitor blocks spinal neuroplasticity essential for the anti-hypersensitivity effects of gabapentin and clonidine in rats with peripheral nerve injury. Journal of Pain 12: 94–100.
Hayashida, K., H. Obata, K. Nakajima, and J.C. Eisenach. 2008. Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology 109: 1077–1084.
Hayashida, K., R. Parker, and J.C. Eisenach. 2007. Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. Anesthesiology 106: 1213–1219.
Helton, T.D., D.J. Kojetin, J. Cavanagh, and W.A. Horne. 2002. Alternative splicing of a β4 subunit proline-rich motif regulates voltage-dependent gating and toxin block of Cav2.1 Ca2+ channels. Journal of Neuroscience 22: 9331–9339.
Hemstreet, B., and M. Lapointe. 2001. Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy. Clinical Therapeutics 23: 520–531.
Hindmarsh, K.W., L. Tan, K. Sankaran, and V.A. Laxdal. 1989. Diurnal rhythms of cortisol, ACTH, and beta-endorphin levels in neonates and adults. Western Journal of Medicine 151: 153–156.
Hon, N.C., and Y.J. Fei. 2008. Prescription pattern of oral healthcare professionals in the use of anticonvulsants for trigeminal neuralgia. Annals of the Royal Australasian College of Dental Surgeons 19: 162–164.
Honarmand, A., M. Safavi, and M. Zare. 2011. Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy. Journal of Medical Sciences Research 16: 1062–1069.
Hoppa, M.B., B. Lana, W. Margas, A.C. Dolphin, and T.A. Ryan. 2012. α2δ expression sets presynaptic calcium channel abundance and release probability. Nature 486: 122–125.
Ifuku, M., M. Iseki, I. Hidaka, Y. Morita, S. Komatus, and E. Inada. 2011. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy. Pain Medicine 12: 1112–1116.
Jacob, P. C., R. P. Chand, and el-S. Omeima. 2000. Asterixis induced by gabapentin. Clin. Neuropharmacol, 23, 53.
Jaggi, A.S., and N. Singh. 2011. Role of different brain areas in peripheral nerve injury-induced neuropathic pain. Brain Research 1381: 187–201.
Jarvis, S.E., and G.W. Zamponi. 2007. Trafficking and regulation of neuronal voltage gated calcium channels. Current Opinion in Cell Biology 19: 474–482.
Jean, W.H., C.C. Wu, M.S. Mok, and W.Z. Sun. 2005. Starting dose of gabapentin for patients with post-herpetic neuralgia—a dose-response study. Acta Anaesthesiologica Taiwanica 43: 73–77.
Jones, S.L. 1991. Descending noradrenergic influences on pain. Progress in Brain Research 88: 381–394.
Kaufman, K.R., and P.J. Struck. 2011. Gabapentin-induced sexual dysfunction. Epilepsy & Behavior 21: 324–326.
Keskinbora, K., A.F. Pekel, and I. Aydinli. 2007. Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: A randomized open trial. Journal of Pain and Symptom Management 34: 183–189.
Kim, Y.S., H.K. Chang, J.W. Lee, Y.H. Sung, S.E. Kim, M.S. Shin, J.W. Yi, J.H. Park, H. Kim, and C.J. Kim. 2009. Protective effect of gabapentin on N-methyl-d-aspartate-induced excitotoxicity in rat hippocampal CA1 neurons. Journal of Pharmacological Science 109: 144–147.
Kirischuk, S., H. Kettenmann, and A. Verkhratsky. 1997. Na+/Ca2+ exchanger modulates kainate-triggered Ca2+ signaling in Bergmann glial cells in situ. FASEB Journal 11: 566–572.
Ko, S.H., H.S. Kwon, J.M. Yu, S.H. Baik, I.B. Park, J.H. Lee, K.S. Ko, J.H. Noh, D.S. Kim, C.H. Kim, J.O. Mok, T.S. Park, H.S. Son, and B.Y. Cha. 2010. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy. Diabetic Medicine 27: 1033–1040.
Kusunose, N., S. Koyanagi, K. Hamamura, N. Matsunaga, M. Yoshida, T. Uchida, M. Tsuda, K. Inoue, and S. Ohdo. 2010. Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain. Molecular Pain 6: 83.
Kwan, K.Y., A.J. Allchorne, M.A. Vollrath, A.P. Christensen, D.S. Zhan, C.J. Woolf, and D.P. Corey. 2006. TRPA1 contributes cold, mechanical, and chemical nociception but is n essential for hair-cell transduction. Neuron 50: 277–289.
Lemos, L., R. Fontes, S. Flores, P. Oliveira, and A. Almeida. 2010. Effectiveness of the association between carbamazepine and peripheral analgesic block with ropivacaine for the treatment of trigeminal neuralgia. Journal of Pain Research 3: 201–212.
Li, C.Y., X.L. Zhang, E.A. Matthews, K.W. Li, A. Kurwa, A. Boroujerdi, J. Gross, M.S. Gold, A.H. Dickenson, G. Feng, and Z.D. Luo. 2006. Calcium channel α2-δ-1 subunit mediates spinal hyperexcitability in pain modulation. Pain 125: 20–34.
Liu, Y., N. Qin, T. Reitz, Y. Wang, and C.M. Flores. 2006. Inhibition of the rat brain sodium channel Nav1.2 after prolonged exposure to gabapentin. Epilepsy Research 70: 263–268.
Lloyd, A., C.S. Boomershine, E.H. Choy, A. Chandran, and G. Zlateva. 2012. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. Journal of Medicinal Economics 15: 481–492.
Lopez, P.R., T. Rachael, S. Leicht, and R.D. Smalligan. 2010. Gabapentin-induced delusions of parasitosis. Southern Medical Journal 103: 711–712.
Luo, Z.D., N.A. Calcutt, E.S. Higuera, C.R. Valder, Y.H. Song, C.I. Svensson, and R.R. Myers. 2002. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. Journal of Pharmacology and Experimental Therapeutics 303: 1199–1205.
Ma, L.L., W. Liu, Y.G. Huang, N. Yang, and P.P. Zuo. 2011. Analgesic effect of gabapentin in a rat model for chronic constrictive injury. Chinese Medical Journal (English Edition) 124: 4304–4309.
Malarkey, E.B., and V. Parpura. 2008. Mechanisms of glutamate release from astrocytes. Neurochemistry International 52: 142–154.
Martin, D.J., D. McClelland, M.B. Herd, K.G. Sutton, M.D. Hall, K. Lee, R.D. Pinnock, and R.H. Scott. 2002. Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology 42: 353–366.
Mich, P.M., and W.A. Horne. 2008. Alternative splicing of the Ca channel beta4 subunit confers specificity for gabapentin inhibition of Cav2.1 trafficking. Molecular Pharmacology 74: 904–912.
Mishra, S., S. Bhatnagar, G.N. Goyal, S.P. Rana, and S.P. Upadhya. 2012. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. American Journal of Hospice & Palliative Care 29: 177–182.
Mittal, M., M. Pasnoor, R.B. Mummaneni, S. Khan, A. McVey, D. Saperstein, L. Herbelin, L. Ridings, Y. Wang, M.M. Dimachkie, and R.J. Barohn. 2011. Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy. Journal of Neuroscience 121: 521–527.
Mixcoatl-Zecuatl, T., G.N. Quinonez-Bastidas, N.L. Caram-Salas, M. Ambriz-Tututi, C.I. Araiza-Saldana, H.I. Rocha-Gonzalez, R. Medina-Santillan, G. Reyes-Garcia, and V. Granados-Soto. 2008. Synergistic antiallodynic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats. Methods and Findings in Experimental and Clinical Pharmacology 30: 431–441.
Miyano, K., H.B. Tang, Y. Nakamura, N. Morioka, A. Inoue, and Y. Nakata. 2009. Paclitaxel and vinorelbine, evoked the release of substance P from cultured rat dorsal root ganglion cells through different PKC isoform-sensitive ion channels. Neuropharmacology 57: 25–32.
Morello, C.M., S.G. Leckband, C.P. Stoner, D.F. Moorhouse, and G.A. Sahagian. 1999. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Archives of Internal Medicine 159: 1931–1937.
Morimoto, S., M. Ito, S. Oda, A. Sugiyama, M. Kuroda, and S. Adachi-Akahane. 2012. Spinal mechanism underlying the antiallodynic effect of gabapentin studied in the mouse spinal nerve ligation model. Journal of Pharmacological Science 118: 455–466.
O’Connor, A.B., K. Noyes, and R.G. Holloway. 2007. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. Journal of the American Geriatrics Society 55: 1176–1184.
Odrcich, M., J.M. Bailey, C.M. Cahill, and I. Gilron. 2006. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: Diurnal pain variation and effects of analgesic therapy. Pain 120: 207–212.
Pandey, C.K., N. Singh, and P.K. Singh. 2008. Gabapentin for refractory idiopathic trigeminal neuralgia. Journal of the Indian Medical Association 106: 124–125.
Paradowski, B., and M. Bilinska. 2003. Gabapentin in the treatment of neuropathic pain in patients with type 2 diabetes mellitus. Pol Merkur Lekarski 15: 61–64.
Park, S., E.S. Ahn, D.W. Han, J.H. Lee, K.T. Min, H. Kim, and Y.W. Hong. 2008. Pregabalin and gabapentin inhibit substance P-induced NF-kappaB activation in neuroblastoma and glioma cells. Journal of Cellular Biochemistry 105: 414–423.
Parsons, B., L. Tive, and S. Huang. 2004. Gabapentin: A pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. American Journal of Geriatric Pharmacotherapy 2: 157–162.
Patarica-Huber, E., N. Boskov, and M. Pjevic. 2011. Multimodal approach to therapy-related neuropathic pain in breast cancer. Journal of BUON 16: 40–45.
Pérez, C., A. Navarro, M.T. Saldaña, X. Masramón, and J. Rejas. 2010. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study. Clinical Therapeutics 32: 1357–1370.
Perloff, M.D., D.E. Thaler, and J.A. Otis. 2011. Anorgasmia with gabapentin may be common in older patients. American Journal of Geriatric Pharmacotherapy 9: 199–203.
Petraglia, F., F. Facchinetti, D. Parrini, G. Micieli, S. De Luca, and A.R. Genazzani. 1983. Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. Hormone Research 17: 147–152.
Polgár, E., J.H. Fowler, M.M. McGill, and A.J. Todd. 1999. The types of neuron which contain protein kinase C gamma in rat spinal cord. Brain Research 833: 71–80.
Quintero, J.E., D.J. Dooley, F. Pomerleau, P. Huettl, and G.A. Gerhardt. 2011. Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: Role of voltage-sensitive Ca2+ α2δ−1 subunit. Journal of Pharmacology and Experimental Therapeutics 338: 240–245.
Rice, A.S., and S. Maton. 2001. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 94: 215–224.
Richardson, C.E., D.W. Williams, and J.G. Kingham. 2002. Gabapentin induced cholestasis. BMJ 325: 635.
Rock, D.M., K.M. Kelly, and R.L. Macdonald. 1993. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Research 16: 89–98.
Rojas, H., C. Colina, M. Ramos, G. Benaim, E.H. Jaffe, C. Caputo, and R. DiPolo. 2007. Na+ entry via glutamate transporter activates the reverse Na+/Ca2+ exchange and triggers Ca(i)2+-induced Ca2+ release in rat cerebellar Type-1 astrocytes. Neurochemistry 100: 1188–1202.
Ross, J.R., K. Goller, J. Hardy, J. Riley, K. Broadley, R. A’hern, and J. Williams. 2005. Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study. Journal of Palliative Medicine 8: 1118–1126.
Rowbotham, M., N. Harden, B. Stacey, P. Bernstein, and L. Magnus-Miller. 1998. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 280: 1837–1842.
Ruessmann, H.J. 2009. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: A real-world study in outpatients. Journal of Diabetes and Its Complications 23: 174–177.
Said, G. 2007. Diabetic neuropathy—a review. Nature Clinical Practice Neurology 3: 331–340.
Saldaña, M.T., C. Pérez, A. Navarro, X. Masramón, and J. Rejas. 2012. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice. Clinical Drug Investigation 32: 401–412.
Sandercock, D., M. Cramer, J. Wu, Y.K. Chiang, V. Biton, and M. Heritier. 2009. Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: Efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Diabetes Care 32: e20.
See, S., E. Hendriks, and L. Hsiung. 2011. Akathisia induced by gabapentin withdrawal. Annals of Pharmacotherapy 45: e31.
Selph, S., S. Carson, R. Fu, S. Thakurta, A. Low, and M. McDonagh. 2011. Drug class review: neuropathic pain: Final update 1 report [Internet]. Portland (OR): Oregon Health & Science University.
Takahashi, H., and N. Shimoyama. 2010. A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. International Journal of Clinical Oncology 15: 46–51.
Takasu, K., H. Ono, and M. Tanabe. 2008. Gabapentin produces PKA-dependent pre-synaptic inhibition of GABAergic synaptic transmission in LC neurons following partial nerve injury in mice. Journal of Neurochemistry 105: 933–942.
Takasusuki, T., and T.L. Yaksh. 2011. The effects of intrathecal and systemic gabapentin on spinal substance P release. Anesthesia and Analgesia 112: 971–976.
Tanabe, M., K. Takasu, N. Kasuya, S. Shimizu, M. Honda, and H. Ono. 2005. Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. British Journal of Pharmacology 144: 703–714.
Taylor, C.P. 1997. Mechanisms of action of gabapentin. Rev Neurol (Paris) 153(suppl 1): 539–545.
Taylor, C.P. 2009. Mechanisms of analgesia by gabapentin and pregabalin–calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain 142: 13–16.
Tsavaris, N., P. Kopterides, C. Kosmas, A. Efthymiou, H. Skopelitis, A. Dimitrakopoulos, E. Pagouni, D. Pikazis, P.V. Zis, and C. Koufos. 2008. Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: A pilot study. Pain Medicine 9: 1209–1216.
Tuccori, M., G. Lombardo, F. Lapi, A. Vannacci, C. Blandizzi, and M. Del Tacca. 2007. Gabapentin-induced severe myopathy. Annals of Pharmacotherapy 41: 1301–1305.
Vadalouca, A., E. Raptis, E. Moka, P. Zis, P. Sykioti, and I. Siafaka. 2012. Pharmacological treatment of neuropathic cancer pain: A comprehensive review of the current literature. Pain Practice 12: 219–251.
Vendel, A. C., M. D. Terry, A. R. Striegel, N. M. Iverson, V. Leuranguer, C. D. Rithner, B. A. Lyons, G. E. Pickard, S. A. Tobet, and W. A. Horne. 2007. Alternative splicing of the voltage-gated Ca2+ channel β4 subunit creates a uniquely folded N-terminal protein binding domain with cell-specific expression in the cerebellar cortex. Journal of Neuroscience 26, 2635–2644 (2006).
Vranken, J.H. 2009. Mechanisms and treatment of neuropathic pain. Central Nervous System Agents in Medicinal Chemistry 9: 71–78.
Walczak, J.S., V. Pichette, F. Leblond, K. Desbiens, and P. Beaulieu. 2005. Behavioural, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain. Neuroscience 132: 1093–1102.
Wallace, V.C., J. Blackbeard, A.R. Segerdahl, F. Hasnie, T. Pheby, S.B. McMahon, and A.S. Rice. 2007. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 130: 2688–2702.
Whittaker, C.A., and R.O. Hynes. 2002. Distribution and evolution of von Willebrand/integrin A domains: Widely dispersed domains with roles in cell adhesion and elsewhere. Molecular Biology of the Cell 13: 3369–3387.
Wodarski, R., A.K. Clark, J. Grist, F. Marchand, and M. Malcangio. 2009. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. European Journal of Pain 13: 807–811.
Xiao, W., A. Boroujerdi, G.J. Bennett, and Z.D. Luo. 2007. Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144: 714–720.
Verkhratsky, A., and F. Kirchhoff. 2007. Glutamate-mediated neuronal-glial transmission. Anat 210: 651–660.
Yaksh, T.L. 2006. Calcium channels as therapeutic targets in neuropathic pain. Journal of Pain 7(1 Suppl 1): S13–S30.
Yamama, Y., K. Nishikawa, T. Funao, T. Mori, and A. Asada. 2010. Intrathecal gabapentin and clonidine synergistically inhibit allodynia in spinal nerve-ligated rats. Life Sciences 87: 565–571.
Yang, R.H., W.T. Wang, J.Y. Chen, R.G. Xie, and S.J. Hu. 2009. Gabapentin selectively reduces persistent sodium current in injured type-A dorsal root ganglion neurons. Pain 143: 48–55.
Yang, R.H., J.L. Xing, J.H. Duan, and S.J. Hu. 2005. Effects of gabapentin on spontaneous discharges and subthreshold membrane potential oscillation of type A neurons in injured DRG. Pain 116: 187–193.
Yang, J.L., B. Xu, S.S. Li, W.S. Zhang, H. Xu, X.M. Deng, and Y.Q. Zhang. 2012. Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats. Molecular Brain 5: 18.
Yeh, C.Y., S.C. Chung, F.L. Tseng, Y.C. Tsai, and Y.C. Liu. 2011. Biphasic effects of chronic intrathecal gabapentin administration on the expression of protein kinase C gamma in the spinal cord of neuropathic pain rats. Acta Anaesthesiologica Taiwanica 49: 144–148.
Yi, H., M.A. Kim, S.K. Back, J.S. Eun, and H.S. Na. 2011. A novel rat forelimb model of neuropathic pain produced by partial injury of the median and ulnar nerves. European Journal of Pain 15: 459–466.
Yoshizumi, M., J.C. Eisenach, and K. Hayashida. 2012a. Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes. European Journal of Pharmacology 677: 87–92.
Yoshizumi, M., R.A. Parker, J.C. Eisenach, and K. Hayashida. 2012b. Gabapentin inhibits γ-amino butyric acid release in the locus coeruleus but not in the spinal dorsal horn after peripheral nerve injury in rats. Anesthesiology 116: 1347–1353.
Zakrzewska, J.M., and R. McMillan. 2011. Trigeminal neuralgia: The diagnosis and management of this excruciating and poorly understood facial pain. Postgraduate Medical Journal 87: 410–416.
Acknowledgments
The authors are grateful to Department of Pharmaceutical Sciences & Drug Research, Punjabi University, Patiala, India for providing technical facilities.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kukkar, A., Bali, A., Singh, N. et al. Implications and mechanism of action of gabapentin in neuropathic pain. Arch. Pharm. Res. 36, 237–251 (2013). https://doi.org/10.1007/s12272-013-0057-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-013-0057-y